These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20015075)

  • 21. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
    Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate.
    Andrews RK; Gorman JJ; Booth WJ; Corino GL; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8326-36. PubMed ID: 2690940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. von Willebrand factor binds to native collagen VI primarily via its A1 domain.
    Hoylaerts MF; Yamamoto H; Nuyts K; Vreys I; Deckmyn H; Vermylen J
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):185-91. PubMed ID: 9164855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Platelet Glycoprotein VI and Tyrosine Kinase Syk in Thrombus Formation on Collagen-Like Surfaces.
    Jooss NJ; De Simone I; Provenzale I; Fernández DI; Brouns SLN; Farndale RW; Henskens YMC; Kuijpers MJE; Ten Cate H; van der Meijden PEJ; Cavill R; Heemskerk JWM
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The collagen-binding leech products rLAPP and calin prevent both von Willebrand factor and alpha2beta1(GPIa/IIa)-I-domain binding to collagen in a different manner.
    Depraetere H; Kerekes A; Deckmyn H
    Thromb Haemost; 1999 Sep; 82(3):1160-3. PubMed ID: 10494781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.
    Girma JP; Kalafatis M; Piétu G; Lavergne JM; Chopek MW; Edgington TS; Meyer D
    Blood; 1986 May; 67(5):1356-66. PubMed ID: 3008890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production and characterization of saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion to collagen.
    Barnes CS; Krafft B; Frech M; Hofmann UR; Papendieck A; Dahlems U; Gellissen G; Hoylaerts MF
    Semin Thromb Hemost; 2001 Aug; 27(4):337-48. PubMed ID: 11547356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
    Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
    Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox.
    Wu WB; Peng HC; Huang TF
    Thromb Haemost; 2001 Dec; 86(6):1501-11. PubMed ID: 11776320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factor.
    Dardik R; Ruggeri ZM; Savion N; Gitel S; Martinowitz U; Chu V; Varon D
    Thromb Haemost; 1993 Sep; 70(3):522-6. PubMed ID: 8259558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains.
    Fretto LJ; Fowler WE; McCaslin DR; Erickson HP; McKee PA
    J Biol Chem; 1986 Nov; 261(33):15679-89. PubMed ID: 3536910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib.
    Sugimoto M; Mohri H; McClintock RA; Ruggeri ZM
    J Biol Chem; 1991 Sep; 266(27):18172-8. PubMed ID: 1917949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys.
    Zhao YM; Jiang M; Ji SD; He Y; Shen F; Li XM; Ruan CG
    Biochem Pharmacol; 2013 Apr; 85(7):945-53. PubMed ID: 23295157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen.
    Lasser G; Guchhait P; Ellsworth JL; Sheppard P; Lewis K; Bishop P; Cruz MA; Lopez JA; Fruebis J
    Blood; 2006 Jan; 107(2):423-30. PubMed ID: 16195328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito.
    Yoshida S; Sudo T; Niimi M; Tao L; Sun B; Kambayashi J; Watanabe H; Luo E; Matsuoka H
    Blood; 2008 Feb; 111(4):2007-14. PubMed ID: 18056842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. von Willebrand factor fragments.
    Meyer D
    Curr Stud Hematol Blood Transfus; 1991; (58):42-5. PubMed ID: 1954772
    [No Abstract]   [Full Text] [Related]  

  • 38. Physical and functional interaction between cell-surface calreticulin and the collagen receptors integrin alpha2beta1 and glycoprotein VI in human platelets.
    Elton CM; Smethurst PA; Eggleton P; Farndale RW
    Thromb Haemost; 2002 Oct; 88(4):648-54. PubMed ID: 12362238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Function of the cysteine-rich domain of the haemorrhagic metalloproteinase atrolysin A: targeting adhesion proteins collagen I and von Willebrand factor.
    Serrano SM; Jia LG; Wang D; Shannon JD; Fox JW
    Biochem J; 2005 Oct; 391(Pt 1):69-76. PubMed ID: 15929722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.